上海赛伦生物技术股份有限公司关于参加2025年上海辖区上市公司三季报集体业绩说明会的公告

Core Viewpoint - Shanghai Sairun Biotechnology Co., Ltd. will participate in the 2025 Shanghai-listed companies' third-quarter collective performance briefing on November 13, 2025, to address investor concerns and discuss the company's Q3 operational results and financial status [2][3]. Group 1: Event Details - The investor briefing will be held online on November 13, 2025, from 15:00 to 16:30 [6][7]. - Investors can participate by logging into the Shanghai Stock Exchange Roadshow Center website [5][6]. - The company encourages investors to submit questions from November 6 to November 12, 2025, for discussion during the briefing [2][5]. Group 2: Participants - Key participants in the briefing will include Chairman Fan Zhihe, General Manager Fan Tiejiong, Deputy General Manager and Board Secretary Cheng Qiong, Chief Financial Officer Liu Jinbao, and Independent Director Liu Junling [4]. Group 3: Contact Information - Investors can contact the company’s Board Secretary Office for inquiries via phone at 021-64959122 or email at dmb@serum-china.com [8]. - After the briefing, the main content and outcomes will be available on the Shanghai Stock Exchange Roadshow Center [8].